De novo pigmentation of amelanotic retinal pigment epithelium – An ex vivo model

Purpose: Retinal Pigment Epithelial (RPE) cells perform critical functions in the visual cycle. Their melanin pigmentation, which is organized into specialized compartments ‐ melanosomes, is highly critical for proper vision. We hereby show an ex vivo model for de novo pigmentation of RPE cells. Methods: A chemical method to induce pigmentation in a non‐pigment model of ARPE‐19 cells was applied using L‐DOPA as a repurposed drug from the current treatment of Parkinson's disease. Results: L‐DOPA was optimized for its toxic effect on ARPE‐19 cells along with pigmentation development. We found 1000 μM L‐DOPA to start inducing pigmentation of RPEs by Day 3, and achieve full pigmentation by Day 5. The gene expression of RPE‐specific markers (Tyrosinase, CRALBP, PEDF) was significantly higher in L‐DOPA‐treated ARPE‐19 compared to non‐treated ones. Positive expression for Tyrosinase was confirmed by ICC at both Day 3 and Day 5 of L‐DOPA treatment. Transmission electron microscopy showed the de novo melanosome formation with ultrastructural features of various stages of maturity (Stage I to IV), apical‐basal polarity, and melanosomes localization on the apical side of the RPEs in the L‐DOPA treated cells. Conclusions: Our study showed that L‐DOPA treatment could induce de novo melanosome formation in amelanotic RPE cells. Keywords: RPE, Melanosomes, L‐DOPA, Pigmentation.